{"id":"W3182206294","doi":"10.1016/j.ejca.2021.05.037","title":"Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Oncology; Metastatic breast cancer; Breast cancer; Placebo; Population; Clinical endpoint; Surgery; Cancer; Confidence interval; Chemotherapy; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005989001,0.002066158,0.006969486,0.0007803597,0.0003402551,0.001778638,0.001041402,0.001992968,0.003551709],"category_scores_gemma":[0.007688303,0.0007413674,0.01302471,0.0008481559,0.0006843817,0.0008946395,0.0007193997,0.002132796,0.0004435885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001285632,"about_ca_system_score_gemma":0.001263937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001080574,"about_ca_topic_score_gemma":0.002451155,"domain_scores_codex":[0.9957393,0.00246348,0.0006675491,0.0005235081,0.0002831397,0.0003230012],"domain_scores_gemma":[0.9965594,0.001584135,0.0008571532,0.0004632082,0.000209698,0.0003264026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9456114,0.0006729161,0.003556353,0.001658584,0.03857557,0.00008580886,0.00006457056,0.0004469397,0.001524378,0.00006022617,0.0003558317,0.007387462],"study_design_scores_gemma":[0.8849906,0.03149015,0.01667613,0.0002822354,0.06237394,0.0001591627,0.0001287811,0.001555578,0.0007181546,0.0005710014,0.0009852198,0.00006910161],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9526158,0.03804847,0.001261816,0.0009121005,0.001011719,0.002949586,0.001823116,0.00008871329,0.001288824],"genre_scores_gemma":[0.9909916,0.003559104,0.0006539324,0.0005982522,0.0004176157,0.001871317,0.001029153,0.0000193473,0.000859635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006969486,"threshold_uncertainty_score":0.03167325,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02218394774989134,"score_gpt":0.3362273108954843,"score_spread":0.3140433631455929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}